
Shirley V. Gembeh
Examiner (ID: 11999, Phone: (571)272-8504 , Office: P/1628 )
| Most Active Art Unit | 1615 |
| Art Unit(s) | 1628, 1615, 1614, 1618 |
| Total Applications | 2053 |
| Issued Applications | 1120 |
| Pending Applications | 147 |
| Abandoned Applications | 807 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 15927781
[patent_doc_number] => 20200155524
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-21
[patent_title] => METHOD FOR REDUCING SIDE EFFECTS FROM ADMINISTRATION OF PHOSPHODIESTERASE-4 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/563435
[patent_app_country] => US
[patent_app_date] => 2019-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13337
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16563435
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/563435 | METHOD FOR REDUCING SIDE EFFECTS FROM ADMINISTRATION OF PHOSPHODIESTERASE-4 INHIBITORS | Sep 5, 2019 | Abandoned |
Array
(
[id] => 16204745
[patent_doc_number] => 20200237735
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-30
[patent_title] => PHARMACEUTICAL COMPOSITIONS CONTAINING A PDE4 INHIBITOR AND A P13 DELTA OR DUAL P13 DELTA-GAMMA KINASE INHIBITOR
[patent_app_type] => utility
[patent_app_number] => 16/557025
[patent_app_country] => US
[patent_app_date] => 2019-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12217
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16557025
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/557025 | Pharmaceutical compositions containing a PDE4 inhibitor and a PI3 delta or dual PI3 delta-gamma kinase inhibitor | Aug 29, 2019 | Issued |
Array
(
[id] => 15586271
[patent_doc_number] => 20200069670
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-05
[patent_title] => DOSAGE REGIMEN FOR AN ALPHA-ISOFORM SELECTIVE PHOSPHATIDYLINOSITOL 3-KINASE INHIBITOR
[patent_app_type] => utility
[patent_app_number] => 16/556111
[patent_app_country] => US
[patent_app_date] => 2019-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15865
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16556111
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/556111 | DOSAGE REGIMEN FOR AN ALPHA-ISOFORM SELECTIVE PHOSPHATIDYLINOSITOL 3-KINASE INHIBITOR | Aug 28, 2019 | Abandoned |
Array
(
[id] => 15678539
[patent_doc_number] => 20200093933
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-26
[patent_title] => BINDING PROTEIN DRUG CONJUGATES COMPRISING ANTHRACYCLINE DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 16/555725
[patent_app_country] => US
[patent_app_date] => 2019-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11992
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16555725
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/555725 | Binding protein drug conjugates comprising anthracycline derivatives | Aug 28, 2019 | Issued |
Array
(
[id] => 16954285
[patent_doc_number] => 11058111
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-07-13
[patent_title] => Use of multiple charged cationic compounds derived from primary amines or polyamines for microbial fouling control in a water system
[patent_app_type] => utility
[patent_app_number] => 16/554435
[patent_app_country] => US
[patent_app_date] => 2019-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 10
[patent_no_of_words] => 22106
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 149
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16554435
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/554435 | Use of multiple charged cationic compounds derived from primary amines or polyamines for microbial fouling control in a water system | Aug 27, 2019 | Issued |
Array
(
[id] => 15432377
[patent_doc_number] => 20200030371
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-30
[patent_title] => METHOD OF ADMINISTRATION AND TREATMENT
[patent_app_type] => utility
[patent_app_number] => 16/546260
[patent_app_country] => US
[patent_app_date] => 2019-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36346
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16546260
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/546260 | Method of administration and treatment | Aug 19, 2019 | Issued |
Array
(
[id] => 15206223
[patent_doc_number] => 20190365798
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-05
[patent_title] => METHOD OF ADMINISTRATION AND TREATMENT
[patent_app_type] => utility
[patent_app_number] => 16/546256
[patent_app_country] => US
[patent_app_date] => 2019-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37537
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16546256
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/546256 | Method of administration and treatment | Aug 19, 2019 | Issued |
Array
(
[id] => 17512121
[patent_doc_number] => 11291232
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-04-05
[patent_title] => Highly soluble Rebaudioside D
[patent_app_type] => utility
[patent_app_number] => 16/539730
[patent_app_country] => US
[patent_app_date] => 2019-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4456
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16539730
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/539730 | Highly soluble Rebaudioside D | Aug 12, 2019 | Issued |
Array
(
[id] => 15586213
[patent_doc_number] => 20200069641
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-05
[patent_title] => METHODS AND COMPOSITIONS FOR REDUCING OR ELIMINATING SYMPTOMS OF WITHDRAWAL FROM DRUGS AND ALCOHOL
[patent_app_type] => utility
[patent_app_number] => 16/530602
[patent_app_country] => US
[patent_app_date] => 2019-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9196
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16530602
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/530602 | Methods and compositions for reducing or eliminating symptoms of withdrawal from drugs and alcohol | Aug 1, 2019 | Issued |
Array
(
[id] => 19423745
[patent_doc_number] => 12083136
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-09-10
[patent_title] => Combination of BCL-2/BCL-XL inhibitors and chemotherapeutic agent and use thereof
[patent_app_type] => utility
[patent_app_number] => 16/630855
[patent_app_country] => US
[patent_app_date] => 2019-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 63
[patent_no_of_words] => 16481
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16630855
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/630855 | Combination of BCL-2/BCL-XL inhibitors and chemotherapeutic agent and use thereof | Jul 30, 2019 | Issued |
Array
(
[id] => 16604717
[patent_doc_number] => 10905701
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-02-02
[patent_title] => Compositions and methods for inhibiting arginase activity
[patent_app_type] => utility
[patent_app_number] => 16/525403
[patent_app_country] => US
[patent_app_date] => 2019-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 17814
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16525403
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/525403 | Compositions and methods for inhibiting arginase activity | Jul 28, 2019 | Issued |
Array
(
[id] => 17670785
[patent_doc_number] => 20220183952
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-16
[patent_title] => FORMULATION FOR THE TOPICAL TREATMENT OF THE SKIN AND RELATED USE
[patent_app_type] => utility
[patent_app_number] => 17/601113
[patent_app_country] => US
[patent_app_date] => 2019-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1595
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17601113
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/601113 | FORMULATION FOR THE TOPICAL TREATMENT OF THE SKIN AND RELATED USE | Jul 28, 2019 | Abandoned |
Array
(
[id] => 17124505
[patent_doc_number] => 20210299273
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-30
[patent_title] => NANOPARTICLE COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/262151
[patent_app_country] => US
[patent_app_date] => 2019-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35361
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -47
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17262151
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/262151 | NANOPARTICLE COMPOSITIONS | Jul 22, 2019 | Abandoned |
Array
(
[id] => 16596505
[patent_doc_number] => 20210023036
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-28
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING THE EYE
[patent_app_type] => utility
[patent_app_number] => 16/519145
[patent_app_country] => US
[patent_app_date] => 2019-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17051
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 164
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16519145
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/519145 | Compositions and methods for treating the eye | Jul 22, 2019 | Issued |
Array
(
[id] => 16741974
[patent_doc_number] => 10966940
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-06
[patent_title] => Methods for the treatment of tinnitus induced by cochlear excitotoxicity
[patent_app_type] => utility
[patent_app_number] => 16/518328
[patent_app_country] => US
[patent_app_date] => 2019-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 11990
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16518328
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/518328 | Methods for the treatment of tinnitus induced by cochlear excitotoxicity | Jul 21, 2019 | Issued |
Array
(
[id] => 15081881
[patent_doc_number] => 20190335751
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-07
[patent_title] => Use of the Antifungal Ilicicolin H in Agriculture
[patent_app_type] => utility
[patent_app_number] => 16/516487
[patent_app_country] => US
[patent_app_date] => 2019-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2961
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16516487
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/516487 | Use of the Antifungal Ilicicolin H in Agriculture | Jul 18, 2019 | Abandoned |
Array
(
[id] => 16548496
[patent_doc_number] => 10881633
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-01-05
[patent_title] => Compositions and methods for stimulating ventilatory and/or respiratory drive
[patent_app_type] => utility
[patent_app_number] => 16/515355
[patent_app_country] => US
[patent_app_date] => 2019-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 13989
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16515355
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/515355 | Compositions and methods for stimulating ventilatory and/or respiratory drive | Jul 17, 2019 | Issued |
Array
(
[id] => 15621209
[patent_doc_number] => 20200081009
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-12
[patent_title] => Inhibition of Chemokine CCL7 or Receptor CCR3 of Same for the Treatment and Diagnosis of Prostate Cancer
[patent_app_type] => utility
[patent_app_number] => 16/511126
[patent_app_country] => US
[patent_app_date] => 2019-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14869
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16511126
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/511126 | Inhibition of Chemokine CCL7 or Receptor CCR3 of Same for the Treatment and Diagnosis of Prostate Cancer | Jul 14, 2019 | Abandoned |
Array
(
[id] => 15615839
[patent_doc_number] => 20200078324
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-12
[patent_title] => SUBSTITUTED AROMATIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR TISSUE SELF-REPAIR AND REGENERATION
[patent_app_type] => utility
[patent_app_number] => 16/510581
[patent_app_country] => US
[patent_app_date] => 2019-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19932
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16510581
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/510581 | Substituted aromatic compounds and pharmaceutical compositions for tissue self-repair and regeneration | Jul 11, 2019 | Issued |
Array
(
[id] => 15206041
[patent_doc_number] => 20190365707
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-05
[patent_title] => METHODS OF AMELIORATING POST-DIALYSIS WASHOUT AND NUTRITIONAL SUPPLEMENTS FOR USE IN SUCH METHODS
[patent_app_type] => utility
[patent_app_number] => 16/509653
[patent_app_country] => US
[patent_app_date] => 2019-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5876
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16509653
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/509653 | METHODS OF AMELIORATING POST-DIALYSIS WASHOUT AND NUTRITIONAL SUPPLEMENTS FOR USE IN SUCH METHODS | Jul 11, 2019 | Abandoned |